BioAdvance News Portfolio News Vesteck

“Vesteck, Inc. Successfully Completes Five Clinical Cases”

By WebmasterApril 6, 2023November 1st, 2024No Comments

“Vesteck, Inc. Successfully Completes Five Clinical Cases”

Previous PostTreventis Partners its Preclinical Program in Alzheimer's Disease with Takeda
Next PostAnnovis Bio Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update